IGF1 and heart disorder: In a UK-based sample of older persons aged 60–64 years, declining serum levels and bioavailability of IGF-I (previously known as Somatomedin C) associated with QTcprolongation, a well-established risk factor for sudden death, independent of sex, SEP, BMI, LV mass, heart disease and hypertension.